The discovery that GPR158 serves as a metabotropic glycine receptor (mGlyR) opened new perspectives on the understanding of the complexity of glycinergic transmission in the CNS, also considering that glycine and GPR158 have been implicated in a number of pathological conditions including depression [9–14]. This evidence concerns the gene GPR158 and major depressive disorder.